Skip to content

Agios cut to neutral at Janney

June 26, 2017

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) was downgraded by investment analysts at Janney Montgomery Scott from a “buy” rating to a “neutral” rating in a research note issued to investors on Monday.

http://bit.ly/2sIC0ah

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: